Exploring new approaches in kidney cancer treatment
Official title: NCI Research Specialist/Clinician Scientist Award for Urologic Oncology Research
Funded at University of California Los Angeles · NIH-10919798 · Data updated 2026-11-12
This study is working to improve how we treat kidney cancer, especially for patients with small tumors, by creating better clinical trials and collaborating with experts to find the best options for care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | September 15, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $115,024 |
| NIH project number | 5R50CA278913-02 |
| Project ID | NIH-10919798 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients diagnosed with kidney cancer, particularly those with small renal masses.
✕Less likely to help
Patients with advanced kidney cancer or those not eligible for clinical trials may not receive benefits from this research.
What this research studies
This research focuses on advancing the understanding and treatment of kidney cancer through innovative clinical trials and collaborative efforts among urologic oncologists, patient advocates, and researchers. The project aims to reduce unnecessary treatments for patients with small renal masses by developing and prioritizing clinical trials that address critical questions in the field. By engaging with the NIH Cooperative Group network, the research seeks to create impactful changes in kidney cancer management and improve patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for kidney cancer patients, minimizing overtreatment.
How similar studies have gone: Previous research has shown success in similar approaches, particularly in the development of clinical trials that focus on reducing overtreatment in cancer care.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Shuch, Brian — University of California Los Angeles
- Study coordinator: Shuch, Brian
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Systems genetics of vascular smooth muscle phenotypes in heart disease
Aims to understand how genetic differences influence vascular smooth muscle cells to improve prevention and treatment of coronary artery disease.
-
Motivation for Alcohol Use in Humans and How It Can Be Measured
This grant explores how people are motivated to drink alcohol and tests a safe, controlled way to study that motivation to inform better treatments for alcohol use disorder.
-
Overcoming CAR T cell resistance with tumor-targeted IL-12 to boost anti-tumor immunity
Aims to make CAR T cell therapy work better for solid tumors by using tumor-focused IL-12 to boost the body’s attack on cancer.
-
PediCODE: A Biorepository and Consortium for CoDE - Congenital Diarrhea and Enteropathy
A nationwide effort to collect clinical data and patient-derived samples to uncover the genetic causes of congenital diarrhea and enteropathy and to build a resource that helps researchers study these diseases.
-
Mentor Moms+: a community-led plan to cut alcohol use and HIV risk during pregnancy in South Africa
A community-based program adapts a trusted peer-led model to help pregnant and lactating people reduce alcohol use and HIV risk in South Africa.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.